Methantheline Bromide
Generic Name: methantheline bromide
Manufactured by SHIRE. Dosage form: TABLET. Route: ORAL. Active ingredients: METHANTHELINE BROMIDE (50MG). Application: NDA007390.
Overview
Manufactured by SHIRE. Dosage form: TABLET. Route: ORAL. Active ingredients: METHANTHELINE BROMIDE (50MG). Application: NDA007390.
Dosage
Available as tablet for oral use.
Related Medications
Tremelimumab
tremelimumab
CTLA-4-directed Blocking Antibody [EPC]
11 DESCRIPTION Tremelimumab-actl, a cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) blocking human IgG2 monoclonal antibody, is produced by recombinant DNA technology in NS0 cell suspension culture and has a molecular weight of 149 kDa. IMJUDO (tremelimumab-actl) injection is a sterile, preservative-free, clear to slightly opalescent, colorless to slightly yellow solution, in a single-dose vial for intravenous infusion after dilution.
Benzalkonium
benzalkonium
Antiseptic
Viltolarsen
viltolarsen
11 DESCRIPTION VILTEPSO (viltolarsen) injection is a sterile, preservative-free, aqueous solution for intravenous administration. VILTEPSO is a clear and colorless solution. VILTEPSO is supplied in single-dose vials containing 250 mg/5 mL viltolarsen (50 mg/mL) in 0.9% sodium chloride. Each milliliter of VILTEPSO contains 50 mg viltolarsen and 9 mg sodium chloride in water for injection.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.